Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial
Gregorc, Vanesa, Dr, Novello, Silvia, MD, Lazzari, Chiara, MD, Barni, Sandro, MD, Aieta, Michele, MD, Mencoboni, Manlio, MD, Grossi, Francesco, MD, Pas, Tommaso De, MD, de Marinis, Filippo, MD, Bearz, Alessandra, MD, Floriani, Irene, PhD, Torri, Valter, MD, Bulotta, Alessandra, MD, Cattaneo, Angela, Grigorieva, Julia, PhD, Tsypin, Maxim, PhD, Roder, Joanna, PhD, Doglioni, Claudio, Prof, Levra, Matteo Giaj, MD, Petrelli, Fausto, MD, Foti, Silvia, MD, Viganò, Mariagrazia, MD, Bachi, Angela, PhD, Roder, Heinrich, PhD
Published in The lancet oncology (01.06.2014)
Published in The lancet oncology (01.06.2014)
Get full text
Journal Article
Somatostatin Analog Therapy in Small Cell Lung Cancer
Tartarone, Alfredo, MD, Lerose, Rosa, PhD, Aieta, Michele, MD
Published in Seminars in nuclear medicine (01.05.2016)
Published in Seminars in nuclear medicine (01.05.2016)
Get full text
Journal Article